Charlene Morrow
Cincinnati Children's Hospital Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charlene Morrow.
Pediatrics | 2014
Allison Mayhew; Tanya L. Kowalczyk Mullins; Lili Ding; Susan L. Rosenthal; Gregory D. Zimet; Charlene Morrow; Jessica A. Kahn
OBJECTIVES: Concerns have been raised that human papillomavirus (HPV) vaccination could lead to altered risk perceptions and an increase in risky sexual behaviors among adolescents. The aim of this study was to assess whether adolescent risk perceptions after the first vaccine dose predicted subsequent sexual behaviors. METHODS: Young women 13 to 21 years of age (N = 339) completed questionnaires immediately after HPV vaccination, and 2 and 6 months later, assessing demographic characteristics, knowledge/attitudes about HPV vaccination, risk perceptions, and sexual behaviors. Risk perceptions were measured by using 2 5-item scales assessing: (1) perceived risk of sexually transmitted infections (STI) other than HPV, and (2) perceived need for safer sexual behaviors after HPV vaccination. We assessed associations between risk perceptions at baseline and sexual behaviors over the next 6 months by using logistic regression, stratifying participants by sexual experience at baseline and age (13–15 vs 16–21 years). RESULTS: Among all sexually inexperienced participants (42.5%), baseline risk perceptions were not associated with subsequent sexual initiation; in age-stratified analyses, girls 16 to 21 years of age who reported lower perceived risk for other STI (an inappropriate perception) were less likely to initiate sex (odds ratio [OR] 0.13, 95% confidence interval [CI] 0.03–0.69). Among all sexually experienced participants (57.5%) and in age-stratified analyses, baseline risk perceptions were not associated with subsequent number of sexual partners or condom use. CONCLUSIONS: Risk perceptions after HPV vaccination were not associated with riskier sexual behaviors over the subsequent 6 months in this study sample.
Vaccine | 2016
Tanya L. Kowalczyk Mullins; Gregory D. Zimet; Susan L. Rosenthal; Charlene Morrow; Lili Ding; Bin Huang; Jessica A. Kahn
OBJECTIVE To examine the association between risk perceptions after human papillomavirus (HPV) vaccination and sexual behaviors and sexually transmitted infection (STI) diagnosis over 30months following vaccination. METHODS Participants included 112 sexually experienced girls aged 13-21years who were enrolled at the time of first HPV vaccination and completed ⩾2 of 4 follow-up visits at 2, 6, 18, 30months and including 30months. At each visit, participants completed surveys assessing risk perceptions (perceived need for safer sexual behaviors, perceived risk of STIs other than HPV) and sexual behaviors. STI testing was done at 6, 18, and 30months. Outcomes were condom use at last intercourse with main male partner, number of sexual partners since last study visit, and STI diagnosis. Associations between risk perceptions and sexual behaviors/STIs were examined using generalized linear mixed models. RESULTS Mean age was 17.9years; 88% were Black; 49% had a history of STI at baseline. Scale scores for perceived need for safer sexual behaviors did not change significantly over time. Scale scores for perceived risk of STIs other than HPV significantly changed (p=0.027), indicating that girls perceived themselves to be more at risk of STIs other than HPV over 30months following vaccination. Multivariable models demonstrated that greater perceived need for safer sexual behaviors following vaccination was associated with condom use (p=0.002) but not with number of partners or STI diagnosis. Perceived risk of STIs other than HPV was not associated with the three outcomes. CONCLUSIONS The finding that perceived risk for STIs other than HPV was not associated with subsequent sexual behaviors or STI diagnosis is reassuring. The association between perceived need for safer sexual behaviors and subsequent condom use suggests that the HPV vaccination visit is an important opportunity to reiterate the importance of safer sexual behaviors to sexually experienced girls.
Journal of Adolescent Health | 2017
Tanya L. Kowalczyk Mullins; Susan L. Rosenthal; Gregory D. Zimet; Lili Ding; Charlene Morrow; Bin Huang; Jessica A. Kahn
PURPOSE We examined longitudinally the relationship between human papillomavirus (HPV) vaccine-related risk perceptions and initiation of sexual activity among adolescent women over 30 months after HPV vaccination. METHODS Participants included 91 sexually inexperienced women aged 13-21 years receiving the HPV vaccine who completed at least three of five study visits. At every visit, participants completed surveys assessing HPV vaccine-related risk perceptions (perceived risk of sexually transmitted infections [STIs] other than HPV, perceived need for safer sexual behaviors), and sexual initiation. Outcomes were sexual initiation and age of sexual initiation. Associations between risk perceptions and outcomes were examined using ordered logistic regression models for sexual initiation and interval censored survival analyses for age of sexual initiation. RESULTS Mean age at baseline was 14.9 years (standard deviation [SD] 1.4). Most participants perceived themselves to be at risk of STIs other than HPV (mean scale score = 4.0/10; SD 2.1) and perceived a need for safer sexual behaviors (mean scale score = 1.5/10; SD 1.5). By 30 months, 65 participants (78%) initiated sex. Perceived risk of STIs and perceived need for safer sexual behaviors were not associated with sexual initiation or age of sexual initiation. Older age at baseline was associated with sooner sexual initiation (p = .02) and older age at sexual initiation (p < .001). Results of ordered logistic regression and survival analyses were unchanged when controlling for baseline age. CONCLUSIONS HPV vaccine-related risk perceptions were not associated with sexual initiation or age of sexual initiation, providing further support that HPV vaccine-related risk perceptions are unlikely to lead to riskier sexual behaviors.
JAMA Pediatrics | 2012
Tanya L. Kowalczyk Mullins; Gregory D. Zimet; Susan L. Rosenthal; Charlene Morrow; Lili Ding; Marcia Shew; J. Dennis Fortenberry; David I. Bernstein; Jessica A. Kahn
Journal of Adolescent Health | 2010
Tanya L. Kowalczyk Mullins; Gregory D. Zimet; Susan L. Rosenthal; Charlene Morrow; Lili Ding; Marcia L. Shew; J. Dennis Fortenberry; David I. Bernstein; Jessica A. Kahn
Research in Nursing & Health | 2018
Charlene Morrow; Rachel Thomas; Lili Ding; Jessica A. Kahn
Journal of Adolescent Health | 2016
Brittany L. Rosen; Charlene Morrow; Lea Widdice; Tanya L. Kowalczyk Mullins; Jessica A. Kahn
Journal of Adolescent Health | 2016
Charlene Morrow; Rachel Thomas; Lili Ding; Jessica A. Kahn
Human Vaccines & Immunotherapeutics | 2016
Lisa Higgins; Kelsie N. Dirksing; Lili Ding; Charlene Morrow; Lea A. Widdice; Jessica A. Kahn
Archive | 2014
Gregory D. Zimet; Charlene Morrow; Jessica A. Kahn; Allison Mayhew; Tanya L. Kowalczyk Mullins; Lili Ding; Susan L. Rosenthal